Anthony Newcombe, Managing Director
Anthony brings 25 years of expertise in biologics and AAV gene therapy. As co-founder and Chief Operating Officer of VectorY Therapeutics, he advanced engineered capsids, scalable AAV manufacturing, and novel gene therapies for neurodegenerative diseases. He previously led tech transfers at Samsung Biologics, conducted 80+ GMP audits at PAREXEL, and supported EU biosimilar approvals through his regulatory CMC expertise.
Advancing Biologics Development
At GSK, Anthony led global process characterisation and validation activities , supporting development and production for Mosquirix, the first malaria vaccine and at Pfizer, he managed technology transfer and scale-up of Tanezumab, a monoclonal antibody for pain treatment. As Managing Director and co-founder of Applied Biopharm, he advises on GMP manufacturing, compliance, QA, process development, and regulatory CMC strategies. He holds a PhD in Physical Biochemistry from The National Institute for Medical Research, UK and a BSc (Hons) in Biochemistry.
Integrated Compliance Solutions
Applied Biopharm Consulting specialises in GMP auditing and compliance, Manufacturing Science & Technology (MSAT), technology transfer, GMP manufacturing, regulatory CMC, and Quality Assurance. We support clients worldwide developing advanced biotherapeutics, including AAV gene therapies, antibodies, PEGylated proteins, vaccines, and recombinant enzymes. Recognised in 2024 as the ‘Best GMP Compliance Service Provider’ by the Irish Enterprise Awards, we deliver tailored solutions to meet the evolving needs of the biopharmaceutical industry.
Get in touch
We look forward to the opportunity to work with you remotely or on-site to support your biopharmaceutical development and manufacturing needs. To contact us, please email contact@appliedbiopharm.com with your information and a brief description of your enquiry and we will respond as soon as possible. If you prefer to speak with someone directly, please feel free to call on
+353 (0)873634486
(UK/GMT)
